Lumigan review

Lumigan is a prostaglandin-like medication often used in eye drops for glaucoma treatment. It acts by reducing interocular pressure, thereby improving vision and averting permanent damage to eyesight. Lumigan does this by increasing the outward flow of fluids found within the eye, which reduces pressure on the optic nerve. It is available in a 0.03% solution.

Lumigan has also been marketed as a cosmetic eyelash lengthener, under the brand name Latisse. However, a more curious potential use being explored for this medication is to lessen ocular fat. Unilateral fat loss in both eyes has been observed, even when it is only applied in a single eye. The effect however seems reversible.

Lumigan is prescribed to patients suffering from ocular hypertension and open angle glaucoma. Latisse on the other hand, may be used to treat hypotrichosis aside from its cosmetic use. Lumigan is administered for patients who find that they cannot use other eye medication for their condition or find that the eye medication previously used was ineffective.

Lumigan is usually administered once a day (usually in the evening) to the affected eye or eyes. It is recommended to use it the same time each day to prevent missing doses. Always follow the prescription and listen to the special instructions given by your doctor.

Lumigan cannot cure glaucoma but manages the interocular pressure. Continue applying Lumigan even if your vision has already improved. Do not discontinue treatment without your doctor's knowledge.

To apply the Lumigan eye drops, first make sure that your hands are clean. Tilt your head back and lightly pull down your lower eyelid to create a pocket. Make sure the dropper nozzle does not touch your eye as you prepare to place the prescribed number of drops into the pocket. Do not place the drops directly onto the eye surface as this may cause irritation. Close the affected eye for 2 to 3 minutes for the medication to work. Do not blink or rub your eyes.

The use of Lumigan eye drops may cause some side effects. These may include pruritus and burning of the eyes, dryness, tearing and other symptoms of eye irritation. See your doctor if these symptoms persist.

More serious side effects include light sensitivity, presence of pink eye or excess redness or skin edema of the affected eyelid. Seek immediate medical attention if these symptoms occur.

Discoloration of the eye to brown has also been observed, as well as the darkening of the skin around the eye. As a side effect, longer and darker eyelashes may result from Lumigan use. While these changes can occur very gradually over time, they can also be permanent changes in the body.

If you use any other topical eye medication, apply it 5 minutes before or after Lumigan application. Remove contact lenses when administering Lumigan eye drops as the soft lenses may absorb the medication. Replace the lenses 15 minutes after the last application of Lumigan.

Inform your doctor if you have inflammation or any other condition of the eye and if you have or have ever had liver or kidney illness. Lumigan may interact with these conditions. Avoid breastfeeding while on Lumigan and avoid pregnancy while taking this medication.

Lumigan has the following structural formula:

Chemical structure of lumigan

• Molecular formula of lumigan is C25H37NO4
• Chemical IUPAC Name is 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide
• Molecular weight is 415.566 g/mol

Generic name: Bimatoprost

  Your Lumigan review